QCG
WVE icon

Quadrant Capital Group’s Wave Life Sciences WVE Stock Holding History

Quadrant Capital Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4K Hold
2,396
– – ﹤0.01% 2043
2025
Q4 		$40.7K Hold
2,396
– – ﹤0.01% 1757
2025
Q3 		$17.5K Buy
+2,396
New +$19.4K ﹤0.01% 1995
2025
Q2 		– Sell
-2,396
Closed -$19.4K – 2649
2025
Q1 		$19.4K Hold
2,396
– – ﹤0.01% 2047
2024
Q4 		$29.6K Hold
2,396
– – ﹤0.01% 1703
2024
Q3 		$19.6K Hold
2,396
– – ﹤0.01% 1897
2024
Q2 		$12K Hold
2,396
– – ﹤0.01% 2057
2024
Q1 		$14.8K Buy
+2,396
New +$12K ﹤0.01% 1962
2021
Q3 		– Sell
-30
Closed – – 2674
2021
Q2 		$0 Buy
+30
New +$196 ﹤0.01% 2591

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return